IMMUNOGENICITY OF INACTIVATED PURIFIED TISSUE-CULTURE VACCINE AGAINST HEPATITIS-A (HEPAVAC) ASSESSED IN LABORATORY RODENTS

被引:1
|
作者
ELBERT, LB
LISITZINA, EA
KUSOV, YY
BALAYAN, MS
机构
[1] Institute of Poliomyelitis and Virus Encephalitides, Russian Academy of Medical Sciences
关键词
TISSUE CULTURE VACCINE AGAINST HEPATITIS-A; LABORATORY RODENTS; VACCINATION SCHEDULES; ADJUVANT;
D O I
10.1016/0264-410X(92)90045-L
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immune response of laboratory rodents (guinea-pigs, CBA and Balb/c mice, Wistar and August rats) to inactivated hepatitis A vaccine was quantitatively assessed. Under comparable conditions of experiment, the mice showed the highest antibody titres and were capable of reacting to the lower doses of immunogen; meanwhile their individual variations in immune response were more pronounced; white rats were the least susceptible to the vaccine, demonstrating the minimal antibody formation; guinea-pigs produced antibody at intermediate levels but the antibody titres were the most homogeneous. The enhancing effect of aluminium hydroxide was observed in guinea-pigs examined at the late postimmunization stage. Differences in immunogenicity of three vaccine lots were essentially similar when these lots were tested as undiluted preparations in guinea-pigs and mice for mean antibody titres and in mice for 50% immune response using serial dilutions of vaccine. All three tests could be routinely employed for vaccine immunogenicity control.
引用
收藏
页码:828 / 832
页数:5
相关论文
共 50 条
  • [21] IMMUNOGENICITY TRIAL OF INACTIVATED HEPATITIS-A VIRUS-VACCINE IN HUMAN VOLUNTEERS
    KUSOV, YY
    ELBERT, LB
    NELGA, IV
    GRISHINA, GK
    DUNAEVSKI, OA
    KHARIN, NV
    MASLOV, YN
    DROZDOV, SG
    BALAYAN, MS
    VACCINE, 1991, 9 (08) : 540 - 541
  • [22] SAFETY AND IMMUNOGENICITY OF AN INACTIVATED HEPATITIS-A VACCINE - EFFECT OF DOSE AND VACCINATION SCHEDULE
    WESTBLOM, TU
    GUDIPATI, S
    DEROUSSE, C
    MIDKIFF, BR
    BELSHE, RB
    JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (05): : 996 - 1001
  • [23] DOWNSTREAM PROCESS-DEVELOPMENT FOR A HIGHLY PURIFIED, INACTIVATED HEPATITIS-A VACCINE
    HAGEN, A
    ABOUD, R
    DEPHILLIPS, P
    ORELLA, CJ
    ARMSTRONG, M
    LEWIS, J
    SITRIN, R
    OLIVER, C
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 9 - BIOT
  • [24] UV-IRRADIATION INACTIVATED TISSUE-CULTURE VACCINE AGAINST ECTHYMA CONTAGIOSUM
    SAWHNEY, AN
    GAGOV, IJ
    MANOLOVA, NH
    DOKLADI NA BOLGARSKATA AKADEMIYA NA NAUKITE, 1972, 25 (04): : 557 - &
  • [25] DETECTION OF IGM AGAINST HEPATITIS-A VIRUS USING TISSUE-CULTURE DERIVED ANTIGEN
    CHITAMBAR, SD
    ARANKALLE, VA
    BANERJEE, K
    INDIAN JOURNAL OF MEDICAL RESEARCH SECTION A-INFECTIOUS DISEASES, 1991, 93 : 19 - 21
  • [26] AN INACTIVATED HEPATITIS-A VIRAL VACCINE OF CELL-CULTURE ORIGIN
    PROVOST, PJ
    HUGHES, JV
    MILLER, WJ
    GIESA, PA
    BANKER, FS
    EMINI, EA
    JOURNAL OF MEDICAL VIROLOGY, 1986, 19 (01) : 23 - 31
  • [27] EFFICACY OF INACTIVATED TISSUE-CULTURE RABIES VACCINE IN DOGS
    STRATING, A
    BUNN, TO
    GOFF, MT
    PHILLIPS, CE
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1975, 167 (09) : 809 - 812
  • [28] SAFETY PROFILE AND IMMUNOGENICITY OF AN INACTIVATED VACCINE DERIVED FROM AN ATTENUATED STRAIN OF HEPATITIS-A
    ELLERBECK, EF
    LEWIS, JA
    NALIN, D
    GERSHMAN, K
    MILLER, WJ
    ARMSTRONG, ME
    DAVIDE, JP
    RHOAD, AE
    MCGUIRE, B
    CALANDRA, G
    PROVOST, PJ
    MIDTHUN, K
    VACCINE, 1992, 10 (10) : 668 - 672
  • [29] ENHANCEMENT OF HEPATITIS-A PROPAGATION IN TISSUE-CULTURE WITH DICHLORORIBOFURANOSYLBENZIMIDAZOLE (DRB)
    WIDELL, A
    HANSSON, BG
    NORDENFELT, E
    OBERG, B
    JOURNAL OF MEDICAL VIROLOGY, 1987, 21 (04) : A15 - A16
  • [30] SAFETY AND IMMUNOGENICITY OF AN INACTIVATED HEPATITIS-A VIRUS-VACCINE IN PRESCHOOL-CHILDREN
    BALCAREK, KB
    BAGLEY, MR
    PASS, RF
    KRAUSE, D
    CLINICAL RESEARCH, 1993, 41 (04): : A766 - A766